PubRank

Catherine Goodman

Author PubWeight™ 77.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012 6.40
2 Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 2008 4.46
3 Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One 2009 3.11
4 Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J 2011 2.99
5 Costs and consequences of large-scale vector control for malaria. Malar J 2008 2.93
6 Is private health care the answer to the health problems of the world's poor? PLoS Med 2008 2.82
7 Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J 2011 2.75
8 Abandoning presumptive antimalarial treatment for febrile children aged less than five years--a case of running before we can walk? PLoS Med 2009 2.46
9 Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med 2009 2.36
10 Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J 2006 2.09
11 Community accountability at peripheral health facilities: a review of the empirical literature and development of a conceptual framework. Health Policy Plan 2012 2.03
12 The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J 2011 2.03
13 Reducing user fees for primary health care in Kenya: Policy on paper or policy in practice? Int J Equity Health 2009 1.95
14 A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Am J Trop Med Hyg 2004 1.91
15 A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS One 2008 1.88
16 Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Malar J 2010 1.74
17 Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J 2006 1.72
18 Determining the orientation of uniaxially rotating membrane proteins using unoriented samples: a 2H, 13C, AND 15N solid-state NMR investigation of the dynamics and orientation of a transmembrane helical bundle. J Am Chem Soc 2007 1.63
19 How equitable is bed net ownership and utilisation in Tanzania? A practical application of the principles of horizontal and vertical equity. Malar J 2009 1.63
20 A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res 2010 1.58
21 Attracting and retaining health workers in rural areas: investigating nurses' views on rural posts and policy interventions. BMC Health Serv Res 2010 1.40
22 Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochem Pharmacol 2006 1.37
23 Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J 2013 1.37
24 Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. Trop Med Int Health 2013 1.35
25 Direct facility funding as a response to user fee reduction: implementation and perceived impact among Kenyan health centres and dispensaries. Health Policy Plan 2010 1.26
26 Engineering ingenuity at iGEM. Nat Chem Biol 2008 1.23
27 Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research. Open Trop Med J 2008 1.14
28 The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells. Mol Cancer Ther 2006 1.07
29 Community and facility-level engagement in planning and budgeting for the government health sector--a district perspective from Kenya. Health Policy 2010 1.07
30 Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys. Trop Med Int Health 2015 1.00
31 A decade of improvements in equity of access to reproductive and maternal health services in Cambodia, 2000-2010. Int J Equity Health 2013 0.96
32 Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention. Malar J 2014 0.96
33 Appealing to altruism: an alternative strategy to address the health workforce crisis in developing countries? J Public Health (Oxf) 2012 0.91
34 A decade of chemical biology. Nat Chem Biol 2010 0.91
35 Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys. Malar J 2013 0.91
36 Expanding Access to Malaria Diagnosis through Retail Shops in Western Kenya: What Do Shop Workers Think? Malar Res Treat 2013 0.90
37 The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in action. Implement Sci 2014 0.89
38 The challenges of achieving high training coverage for IMCI: case studies from Kenya and Tanzania. Health Policy Plan 2010 0.87
39 A novel vitamin D derivative activates bone morphogenetic protein signaling in MCF10 breast epithelial cells. Mol Pharmacol 2006 0.85
40 Analyzing the equity of public primary care provision in Kenya: variation in facility characteristics by local poverty level. Int J Equity Health 2012 0.82
41 The policy-practice gap: describing discordances between regulation on paper and real-life practices among specialized drug shops in Kenya. BMC Health Serv Res 2014 0.82
42 Research Involving Health Providers and Managers: Ethical Issues Faced by Researchers Conducting Diverse Health Policy and Systems Research in Kenya. Dev World Bioeth 2016 0.82
43 Physical therapists as diagnosticians: drawing the line on diagnosing pathology. J Orthop Sports Phys Ther 2006 0.81
44 Are Health Facility Management Committees in Kenya ready to implement financial management tasks: findings from a nationally representative survey. BMC Health Serv Res 2013 0.80
45 Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya. Soc Sci Med 2013 0.79
46 Making sense of nonsense. Nat Chem Biol 2014 0.76
47 Evaluation of the Affordable Medicines Facility--malaria - Authors' reply. Lancet 2013 0.75
48 Rick Morimoto. Nat Chem Biol 2014 0.75
49 The fallacy of competing interest statements: no shortcut to rigour in research. J R Soc Med 2009 0.75
50 Perry Frey. Nat Chem Biol 2009 0.75
51 From students to scientists at XLAB. Nat Chem Biol 2009 0.75
52 Neurobiology: Tracking the scent. Nat Chem Biol 2016 0.75
53 Metabolism: Some assembly required. Nat Chem Biol 2015 0.75
54 Synthetic biology: beta testing. Nat Chem Biol 2012 0.75
55 Focus on chemical systems biology. In this issue. Nat Chem Biol 2008 0.75
56 Nature Chemical Biology. In this issue. Nat Chem Biol 2008 0.75
57 Metalloenzymes: A tungsten triple play. Nat Chem Biol 2015 0.75
58 Glycobiology: Interior decorating. Nat Chem Biol 2015 0.75
59 Marlene Haffner. Nat Chem Biol 2006 0.75
60 Metals: A hydride out of hiding. Nat Chem Biol 2015 0.75
61 Regulation: positively alarming. Nat Chem Biol 2012 0.75
62 Judit Puskas. Nat Chem Biol 2010 0.75
63 Erratum: Rick Morimoto. Nat Chem Biol 2015 0.75
64 Pamela Silver. Nat Chem Biol 2007 0.75
65 Natural products at the Hans Knöll Institute. Nat Chem Biol 2007 0.75
66 Jean-Marie Lehn. Nat Chem Biol 2007 0.75
67 Monell chemical senses center. Nat Chem Biol 2009 0.75
68 Metalloenzymes: Getting the gold. Nat Chem Biol 2016 0.75